Browse by category

An increasing proportion of patients who undergo metabolic and bariatric surgery MBS start taking glucagon-like 1 peptide receptor...

Patients waiting for operations could safely use glucagon-like peptide-1 receptor agonists (GLP-1 RAs) to lose excess weight and reduce...

Nearly 12% of Americans have used GLP-1 drugs for weight loss, including about one-fifth of women aged 50 to 64, according to report from...

Data from the UK’s medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), has revealed that since...

Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 receptor...

People who have bariatric and metabolic surgery (BMS) are significantly less likely to develop psychiatric disorders compared to those...

Over two percent of adult patients now take a GLP-1 drug to treat overweight or obesity, according to a FAIR Health white paper entitled,...

Children who are living with severe obesity are more likely to experience a clinically relevant change in BMI when GLP-1 agonist drugs...

Individuals who take liraglutide or semaglutide for weight loss reduced their alcohol consumption by almost two-thirds in four months,...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in adults with...